Clinical trial
Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's…
NCT00165412 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00165412 |
|---|---|
| Title | Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease |
| Official title | Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Beth Israel Deaconess Medical Center |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer, Hodgkin's Disease |
| Intervention type | Procedure |
| Interventions | breast MRI, Mammogram |
| Enrollment | 148 |
| Start date | Jul 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Sep 14, 2005 |
| Last update posted | May 2, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: